6th Global Nonalcoholic Steatohepatitis (NASH) Congress

6th Global Nonalcoholic Steatohepatitis (NASH) Congress is organized by Global Engage Ltd and will be held from Mar 02 - 03, 2023 at London Heathrow Marriott Hotel, Hayes, London, England, United Kingdom.,Description:,NASH continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing our understanding of the disease’s mechanisms. Developments in non-invasive diagnostic biomarkers continue to offer the hope that they will replace liver biopsies and there have been improvements to in vivo liver models. All these are the focus of this year’s congress as well as new preclinical and clinical research. The most promising therapeutics in development and business case studies will also be featured at this meeting.,How You Will Benefit:,• Learn how semaglutide and combination therapies can address the metabolic drivers of NASH,• Explore the advances in anti-obesity medications as well as research into the efficacy of exercise as medicine for patients with NAFLD,• Hear about the role of adaptive and innate immune cells in driving NASH-HCC and the consequences for therapy,• Investigate how non-invasive tests may replace liver biopsy as the referent standard for the pragmatic clinical management of NAFLD,• Examine the relationship between type 2 diabetes and NAFLD and relevant treatments for NAFLD,• Get an update on an innovative phase 2b/3, placebo-controlled, global pivotal study into Belapectin,• Hear about early career research offering insights into the pathophysiology and treatment of pediatric NAFLD,• Join our expert-led roundtable discussions covering innovation, multi-omics and AI/Machine learning,• Question a panel about strategies and approaches that move forward the development of successful NASH therapeutics,• Enter the poster competition to win a speaking slot on the agenda,• Join the drinks reception at the end of Day One